Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide versus sitagliptin added to metformin in type 2 diabetes
2007-003937-17Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Jan 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial of liraglutide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Novo Nordisk. Primary endpoint: HbA1c change from baseline at 26 weeks. Started Jan 2008; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-003937-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003937-17.